Very low density lipoprotein physiology

Jump to navigation Jump to search

WikiDoc Resources for Very low density lipoprotein physiology

Articles

Most recent articles on Very low density lipoprotein physiology

Most cited articles on Very low density lipoprotein physiology

Review articles on Very low density lipoprotein physiology

Articles on Very low density lipoprotein physiology in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Very low density lipoprotein physiology

Images of Very low density lipoprotein physiology

Photos of Very low density lipoprotein physiology

Podcasts & MP3s on Very low density lipoprotein physiology

Videos on Very low density lipoprotein physiology

Evidence Based Medicine

Cochrane Collaboration on Very low density lipoprotein physiology

Bandolier on Very low density lipoprotein physiology

TRIP on Very low density lipoprotein physiology

Clinical Trials

Ongoing Trials on Very low density lipoprotein physiology at Clinical Trials.gov

Trial results on Very low density lipoprotein physiology

Clinical Trials on Very low density lipoprotein physiology at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Very low density lipoprotein physiology

NICE Guidance on Very low density lipoprotein physiology

NHS PRODIGY Guidance

FDA on Very low density lipoprotein physiology

CDC on Very low density lipoprotein physiology

Books

Books on Very low density lipoprotein physiology

News

Very low density lipoprotein physiology in the news

Be alerted to news on Very low density lipoprotein physiology

News trends on Very low density lipoprotein physiology

Commentary

Blogs on Very low density lipoprotein physiology

Definitions

Definitions of Very low density lipoprotein physiology

Patient Resources / Community

Patient resources on Very low density lipoprotein physiology

Discussion groups on Very low density lipoprotein physiology

Patient Handouts on Very low density lipoprotein physiology

Directions to Hospitals Treating Very low density lipoprotein physiology

Risk calculators and risk factors for Very low density lipoprotein physiology

Healthcare Provider Resources

Symptoms of Very low density lipoprotein physiology

Causes & Risk Factors for Very low density lipoprotein physiology

Diagnostic studies for Very low density lipoprotein physiology

Treatment of Very low density lipoprotein physiology

Continuing Medical Education (CME)

CME Programs on Very low density lipoprotein physiology

International

Very low density lipoprotein physiology en Espanol

Very low density lipoprotein physiology en Francais

Business

Very low density lipoprotein physiology in the Marketplace

Patents on Very low density lipoprotein physiology

Experimental / Informatics

List of terms related to Very low density lipoprotein physiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Very Low-Density Lipoprotein (VLDL) is a lipoprotein subclass. It is assembled in the liver from cholesterol and apolipoproteins. It is converted in the bloodstream to low-density lipoprotein (LDL). VLDL particles have a diameter of 30-80 nm. VLDL transports endogenous products where chylomicrons transport exogenous (dietary) products.

Function

VLDL transports endogenous triglycerides, phospholipids, cholesterol and cholesteryl esters. It functions as the body's internal transport mechanism for lipids.

Changes during circulation

Nascent VLDL circulates in blood and picks up apolipoprotein C-II and apolipoprotein E donated from High-Density Lipoprotein (HDL). At this point, the nascent VLDL becomes a mature VLDL. Once in circulation, the VLDL will come in contact with Lipoprotein lipase (LPL) in the capillary beds in the body (adipose, cardiac, and skeletal muscle). The LPL will remove triglycerides from the VLDL for storage or energy production.

The VLDL now meets back up with HDL where apoC-II is transferred back to the HDL (but keeps apoE). In addition to this, the HDL transfers cholesteryl esters to the VLDL in exchange for phospholipids and triglycerides (via cholesteryl ester transfer protein).

As more and more triglycerides are removed from the VLDL because of the action of the LPL enzyme, the composition of the molecule changes, and it becomes intermediate density lipoprotein (IDL).

50% of IDL are recognized by receptors in the liver cells (because of the apoB-100 and apoE they contain) and are endocytosed.

The other 50% of IDL lose their apoE. When their cholesterol content becomes greater than the triglyceride content, they become low-density lipoprotein (LDL), with the primary apolipoprotein being apoB-100. The LDL is taken into a cell via the LDL receptor (endocytosis) where the contents are either stored, used for cell membrane structure, or converted into other products (steroid hormones or bile acids).

VLDL and disease

VLDL levels have been correlated with accelerated rates of atherosclerosis, and are elevated in a number of diseases and metabolic states.

The uniqueness of this correlation is disputed by Harchaoui and Boekholdt http://www.medscape.com/viewarticle/551425

See also


de:Very low density lipoprotein he:VLDL fi:Very low density lipoprotein

Template:WH Template:WS